Month: January 2016

FDA approves first drug to show survival benefit in liposarcoma

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug. “Halaven is …

FDA approves first drug to show survival benefit in liposarcoma Read More »

Positive Findings May Lift FDA Hold On Zafgen’s Obesity Drug Trials

Biotech giant Zafgen Inc. feels hopeful in the possible revival of FDA review process of its controversial obesity drug after the release of positive report on the company’s experimental medication. Following the deaths of two patients during its drug trials, the Food and Drug Administration (FDA) ordered a halt on experiments effectively leaving the regulatory …

Positive Findings May Lift FDA Hold On Zafgen’s Obesity Drug Trials Read More »

Compounding pharmacy recalls medications

Abbott’s Compounding Pharmacy in Berkeley, Calif., is voluntarily recalling all unexpired lots of sterile compounded products because of lack of sterility assurance. The compounded medications include injectable medications, sterile solutions, eye drops, and eye ointments. All recalled products were distributed to patients, physician offices and clinics, and veterinarians within California. The recall was issued after …

Compounding pharmacy recalls medications Read More »

3 Scorned Biotechs Destined to Rebound

This commentary originally appeared on Real Money Pro at 10:00 a.m. on Jan. 15, 2016. Click here to learn about this dynamic market information service for active traders. The market staged a nice rebound Thursday as equities clawed back a good portion of Wednesday’s losses. Helping the rally was crude oil, which had a rare up day in 2016. Also …

3 Scorned Biotechs Destined to Rebound Read More »

Utah fears thousands infected in hepatitis C outbreak after exposure to hospital nurse

More than 7,000 patients at a Utah hospital were potentially exposed to an “outbreak” of hepatitis C after coming into contact with an infected former nurse – but less than half have come in for free testing to find out if they have the disease. “We do consider this an outbreak,” Angela Dunn, a physician …

Utah fears thousands infected in hepatitis C outbreak after exposure to hospital nurse Read More »

Researchers Link FDA Actions to Decrease in LABA Use in Asthma Treatment

A recent study finds an association between regulatory actions by the US Food and Drug Administration (FDA) and the use of long-acting β2-agonists (LABA) commonly used to treat asthma. The study, published in the Journal of Allergy and Clinical Immunology in December, was conducted by a team of researchers at Kaiser Permanente, Harvard Medical School, …

Researchers Link FDA Actions to Decrease in LABA Use in Asthma Treatment Read More »

Chipotle Outbreaks At Center Of FDA Investigation

MIAMI (CBSMiami) — Chipotle Mexican Grill has been served with a subpoena by a federal grand jury in connection to illnesses at one of its California restaurants. The company announced Wednesday that U.S. Attorney’s Office and the Food and Drug Administration are investigating a norovirus outbreak that occurred over the summer in the state. Last …

Chipotle Outbreaks At Center Of FDA Investigation Read More »

FDA issues safety alert for antifungal medication dosages, approves label revisions

The FDA issued a safety announcement today warning prescribers, pharmacists and patients that differences in dosing regimens between the two oral formulations of the antifungal Noxafil can lead to dosing errors. Noxafil (posaconazole, Merck) is approved for the treatment of invasive fungal infections caused by Aspergillus and Candida in patients aged 13 years or older with weakened immune systems, according to …

FDA issues safety alert for antifungal medication dosages, approves label revisions Read More »